Generali Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Generali Asset Management's PFE Position: Q2 2026 in Review
Generali Asset Management increased its Pfizer (PFE) stake by 24% in Q2 2026, buying an estimated $1.27M and bringing the position to 255,024 shares worth $6.14M. The position accounts for 0.11% of the portfolio, ranked #171.
Generali Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.5M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Generali Asset Management held 255,024 shares of Pfizer worth $6.14M as of Q2 2026.
- Generali Asset Management bought 48,630 Pfizer shares in Q2 2026, an estimated $1.27M.
- Pfizer made up 0.11% of Generali Asset Management's portfolio in Q2 2026, its #171 holding.
- Generali Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
- Generali Asset Management's Pfizer position peaked at $11.5M in Q4 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.